Axogen (AXGN) Cash from Investing Activities Growth (5y) (2015 - 2026)
Axogen (AXGN) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn |
| 10 | Axogen | 2.44 Bn | 2.33 Bn | 50.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.22% |
| Mar 31, 2026 | -82.69% |
| Dec 31, 2025 | 17.17% |
| Sep 30, 2025 | 29.23% |
| Jun 30, 2025 | -19.77% |
| Mar 31, 2025 | -30.98% |
| Dec 31, 2024 | -15.55% |
| Sep 30, 2024 | -49.34% |
| Jun 30, 2024 | -17.58% |
| Mar 31, 2024 | -19.32% |
| Dec 31, 2023 | -15.24% |
| Sep 30, 2023 | 15.51% |
| Jun 30, 2023 | 105.53% |
| Mar 31, 2023 | -9.43% |
| Dec 31, 2022 | -19.67% |
| Sep 30, 2022 | 66.10% |
| Jun 30, 2022 | 54.36% |
| Mar 31, 2022 | -108.61% |
| Dec 31, 2021 | -103.79% |
| Sep 30, 2021 | -99.17% |